Analysis of the mortality probability of preoperative MRI features in malignant astrocytomas.

AIM The aim of the present study is to analyze the effects of the MRI features on the recurrence time and prognosis, and to emphasize the analyses of mortality risks in malignant astrocytomas. MATERIAL AND METHODS The effects of preoperative MRI features on prognosis were studied for follow-up period of 45 months, from November 1999 to August 2003, on a total of 79 patients' 41 cases of total resection and 38 cases of subtotal resection diagnosed to have malignant astrocytoma subsequent to craniotomy. RESULTS The cases of gross total resection had 2.2 times as high survival rate as those in the subtotal resection group (p < 0.01). The comparison of the cases in the groups in relation to their ages revealed that mortality rate rose 4.35 times (p < 0.01) in the age group of 60 years and above, and 2.1 times in the age group of 45-59 years. When cases without necrosis were compared with the group containing necrosis of grade 1, 2, 3, it was observed that the probability of mortality increased 3.84 (p < 0.01), 4.15 times (p < 0.01) in the case of necrosis of grade 2 and 3, respectively by means of Cox regression model. CONCLUSION Necrosis in preoperative MRI of malignant astrocytomas seems to be an important clinical marker of the prognosis.

[1]  S L Fedder.  The limited value of cytoreductive surgery in elderly patients with malignant gliomas. , 1994, Neurosurgery.

[2]  P. Kleihues,et al.  Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. , 1988, Journal of neurosurgery.

[3]  I. Ciric,et al.  Neurosurgical Outcomes in a Modern Series of 400 Craniotomies for Treatment of Parenchymal Tumors , 1998 .

[4]  Z L Gokaslan,et al.  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.

[5]  M. Mikhael,et al.  Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. , 1987, Neurosurgery.

[6]  J. Maroon,et al.  The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. , 1991, Neurosurgery.

[7]  B A Kall,et al.  Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. , 1987, Journal of neurosurgery.

[8]  J. Nazzaro,et al.  The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. , 1990, Journal of neurosurgery.

[9]  L D Lunsford,et al.  Survival after stereotactic biopsy of malignant gliomas. , 1988, Neurosurgery.

[10]  P. Gutin,et al.  Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. , 1995, International journal of radiation oncology, biology, physics.

[11]  L. S. Adelman.  Grading astrocytomas. , 1994, Neurosurgery clinics of North America.

[12]  Kiyoshi Sato,et al.  Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas , 1995, Cancer.

[13]  R L Ehman,et al.  Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. , 1988, Radiology.

[14]  P J Kelly,et al.  Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. , 1993, Journal of neurosurgery.

[15]  P. Kelly,et al.  Grading of astrocytomas: A simple and reproducible method , 1988, Cancer.

[16]  K. Takakura,et al.  Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. , 1997, Neurosurgery.

[17]  D. Schoenfeld,et al.  Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas , 1983, Cancer.

[18]  Susan M. Chang,et al.  Age and Radiation Response in Glioblastoma Multiforme , 2001, Neurosurgery.

[19]  J. Cairncross,et al.  Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. , 1989, Journal of neurosurgery.

[20]  P. Burger,et al.  COMPUTERIZED TOMOGRAPHIC AND PATHOLOGIC STUDIES OF THE UNTREATED, QUIESCENT AND RECURRENT GLIOBLASTOMA MULTIFORME , 1983 .

[21]  P. Kelly,et al.  Stereotactic biopsy and resection of thalamic astrocytomas. , 1989, Neurosurgery.

[22]  Raymond Sawaya,et al.  Prognostic significance of preoperative MRI scans in glioblastoma multiforme , 2004, Journal of Neuro-Oncology.

[23]  L. Bozzao,et al.  Radiological assessment of necrosis in glioblastoma: variability and prognostic value , 1998, Neuroradiology.

[24]  M. Salcman,et al.  Effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma. , 1982, Neurosurgery.

[25]  Susan M. Chang,et al.  Necrosis as a prognostic factor in glioblastoma multiforme , 1996, Cancer.

[26]  P. Kelly.  Survival and Functional Status after Resection of Recurrent Glioblastoma Multiforme , 1998 .

[27]  D P Byar,et al.  Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. , 1983, Cancer treatment reports.

[28]  Klaus Sartor,et al.  Early Postoperative Magnetic Resonance Imaging after Resection of Malignant Glioma , 1995 .

[29]  S B Green,et al.  Patient age, histologic features, and length of survival in patients with glioblastoma multiforme , 1987, Cancer.

[30]  E. Antman.  Design and Conduct of Clinical Trials , 2012 .

[31]  Webster K. Cavenee,et al.  Pathology and genetics of tumours of the nervous system. , 2000 .

[32]  E. Gehan,et al.  Prognostic factors for patients with brain tumors. , 1977, National Cancer Institute monograph.

[33]  Paul S Mischel,et al.  MR imaging correlates of survival in patients with high-grade gliomas. , 2005, AJNR. American journal of neuroradiology.

[34]  M. Prados,et al.  Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. , 1992, International journal of radiation oncology, biology, physics.